The Study That Changed Everything
In March 2025, a team of researchers at Nagoya University in Japan published a landmark study in the peer-reviewed journal Environmental Health and Preventive Medicine. The paper presented findings that a specific sound frequency -- 100 Hz -- could significantly reduce motion sickness symptoms when delivered through standard headphones.
This was not a minor observation. The study demonstrated a non-pharmacological, non-invasive approach to one of the most common travel-related ailments affecting an estimated one in three people worldwide. The implications were immediate: if sound alone could reduce motion sickness, it could replace or complement medications that cause drowsiness, dry mouth, and other unwanted side effects.
Within a year of publication, Samsung incorporated the findings into their Galaxy Health ecosystem with a feature called Hearapy, and independent developers (including RideCalm) built dedicated apps to make the technology accessible to everyone.
Study Design: 82 Participants, 3 Scenarios
What makes the Nagoya University study particularly compelling is its rigorous, multi-scenario design. The researchers did not test their hypothesis in just one controlled environment -- they validated it across three distinct motion contexts.
Scenario 1: Controlled Swing
The first experiment used a mechanical swing that produced consistent, repeatable motion. Participants were seated and exposed to lateral swinging motion while either listening to the 100Hz tone or a control sound. This controlled environment allowed researchers to isolate the effect of the sound frequency from other variables.
Scenario 2: Driving Simulator
The second scenario used a driving simulator with a winding road course designed to reliably induce motion sickness symptoms. The simulator provided visual-vestibular conflict -- the participants saw a moving road environment while their bodies remained stationary. This is the same mechanism that causes cybersickness in VR.
Scenario 3: Real Vehicle
The third and most practically relevant test placed participants in an actual vehicle driven on a course with curves and varying speeds. This scenario most closely mirrors the real-world conditions where people experience motion sickness -- riding in a car, bus, or taxi.
Across all three scenarios, participants who received the 100Hz sound exposure before the motion stimulus reported significantly reduced motion sickness symptoms compared to control groups. The effect was consistent and reproducible.
The Mechanism: How 100Hz Stimulates the Otolith Organs
Understanding why specifically 100Hz works requires looking at the anatomy of the inner ear. The vestibular system contains two types of motion sensors: the semicircular canals (which detect rotation) and the otolith organs (which detect linear acceleration and gravity).
The otolith organs -- the utricle and saccule -- are the key players in this research. They contain a gelatinous membrane studded with tiny calcium carbonate crystals called otoconia. When you move linearly (forward, backward, up, down) or tilt your head, these crystals shift, bending hair cells underneath them. These hair cells convert the mechanical movement into electrical signals sent to the brain.
The Nagoya University researchers found that 100Hz is the resonant frequency of the otoconia crystals. When sound at this frequency reaches the inner ear through bone conduction from headphones, the otoconia vibrate in a way that provides additional vestibular input to the brain. This supplementary stimulation appears to help the brain better calibrate its sense of position and motion.
"The 100Hz frequency selectively stimulates the otolith organs, providing supplementary vestibular information that helps resolve the sensory conflict between visual and vestibular inputs during passive transport."
Why This Reduces Motion Sickness
Motion sickness is caused by sensory conflict -- when your eyes and inner ear send contradictory signals to the brain about your movement. For example, when reading in a car, your eyes see a stationary page while your vestibular system detects turns, acceleration, and bumps.
The 100Hz stimulation appears to work by pre-activating the otolith system, making it more responsive and accurate in detecting actual motion. With better vestibular input, the brain can more easily reconcile the signals from your eyes and inner ear, reducing the conflict that triggers nausea.
Reducing Sympathetic Nerve Activation
The researchers also measured autonomic nervous system responses in their participants. Motion sickness triggers a cascade of sympathetic nervous system activation -- the same fight-or-flight response associated with stress. This manifests as cold sweats, increased heart rate, pallor, and nausea.
Participants who received the 100Hz exposure showed reduced sympathetic nerve activation during subsequent motion exposure. Their bodies simply did not enter the same stress response that typically accompanies motion sickness. Heart rate variability data confirmed that the 100Hz group maintained better autonomic balance compared to controls.
This is a critical distinction from medications. Antihistamines and anticholinergics work by suppressing the brain's response to vestibular signals. The 100Hz approach, by contrast, appears to improve the quality of vestibular information the brain receives, addressing the problem at its source rather than masking the symptoms downstream.
60 Seconds of Exposure, Up to 2 Hours of Relief
Perhaps the most remarkable finding from the study is the duration of effect relative to exposure time. Participants listened to the 100Hz tone for just 60 seconds before being exposed to motion. The protective effect persisted for up to 2 hours.
This disproportionate ratio -- one minute of sound providing two hours of benefit -- suggests that the stimulation triggers a longer-lasting physiological change in vestibular processing, not just a momentary distraction. The researchers hypothesized that the brief stimulation "primes" the otolith system, keeping it in an enhanced state of responsiveness for an extended period.
For practical purposes, this means a traveler can put on headphones, play the tone for one minute before or at the start of their journey, and expect reduced symptoms for most short-to-medium trips.
Samsung Validated the Research with Hearapy
In March 2026, Samsung became the first major technology company to commercialize the Nagoya University findings. Their Hearapy feature, built into Samsung Health for Galaxy devices, delivers the same 100Hz frequency through Galaxy Buds earbuds.
Samsung's involvement was significant for several reasons. It represented independent validation of the research by a major corporation with resources to conduct its own testing. It also brought mainstream attention to sound-based motion sickness relief, moving it from an academic paper to a consumer product used by millions.
However, Hearapy remains limited to the Samsung ecosystem: Galaxy phones paired with Galaxy Buds. This left hundreds of millions of iPhone users and those with other headphone brands without access to the technology.
How RideCalm Implements the Research Protocol
RideCalm was built from the ground up to faithfully implement the protocol described in the Nagoya University study while making it accessible to anyone with an iPhone and any pair of headphones.
Precision Tone Generation
RideCalm generates a pure 100Hz sine wave using the device's audio engine. The frequency is mathematically precise -- not a recording that could degrade or drift.
Guided 60-Second Session
The app guides you through the exact 60-second exposure described in the research, with volume calibration to ensure the tone reaches an effective level.
2-Hour Relief Timer
After your session, a live countdown shows exactly how long your relief window lasts -- so you know when to re-play for longer journeys.
Trip Logging and Tracking
Log your travel type and how you felt afterward. Over time, you build a personal dataset that helps you understand your response to the therapy across different scenarios.
What This Means for the Future
The Nagoya University research represents a paradigm shift in how we think about motion sickness. For over a century, the primary approach has been pharmaceutical -- blocking signals in the brain to reduce nausea at the cost of alertness and cognitive function.
Sound frequency therapy offers a fundamentally different approach: improving the quality of sensory information rather than suppressing it. No drowsiness, no side effects, no prescriptions, no planning ahead. Just 60 seconds of sound through the headphones already in your pocket.
As researchers continue to study vestibular stimulation and as consumer technology makes these findings accessible, sound therapy may become the default first-line approach for motion sickness -- much like how blue-light glasses became a mainstream response to digital eye strain.
The research is here. The technology is available. For anyone who has ever felt nauseous in a car, on a boat, or during a flight, 100Hz sound therapy offers a new option that was simply not available before 2025.
